- Discovery of small molecule mechanistic target of rapamycin inhibitors as anti-aging and anti-cancer therapeutics2022 | Faculty of Medicine in Hradec Králové
- MicroRNA-34a activation in tuberous sclerosis complex during early brain development may lead to impaired corticogenesis2021 | Second Faculty of Medicine
- Treatment of Metastatic Renal Cell Carcinoma2018 | First Faculty of Medicine
- Loss of Neurological Disease HSAN-I-Associated Gene SPTLC2 Impairs CD8(+) T Cell Responses to Infection by Inhibiting T Cell Metabolic Fitness2019 | Second Faculty of Medicine
- Contemporary mTOR inhibitor scaffolds to diseases breakdown: A patent review (2015-2021)2022 | Publication without faculty affiliation
- Coding and small non-coding transcriptional landscape of tuberous sclerosis complex cortical tubers: implications for pathophysiology and treatment2017 | Second Faculty of Medicine
- Phenotype, penetrance, and treatment of 133 cytotoxic T-lymphocyte antigen 4-insufficient subjects2018 | Second Faculty of Medicine
- The coding and non-coding transcriptional landscape of subependymal giant cell astrocytomas2020 | Second Faculty of Medicine